Bryan Garnier initiated coverage of Adaptimmune with a Buy rating and $3.60 price target.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on ADAP:
Bryan Garnier initiated coverage of Adaptimmune with a Buy rating and $3.60 price target.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on ADAP: